Literature DB >> 21278218

Utilization of oncology services and receipt of treatment: a comparison between patients with breast, colon, rectal, or lung cancer.

X Li1, C Butts, D Fenton, K King, A Scarfe, M Winget.   

Abstract

BACKGROUND: Higher awareness could translate into better care for patients with breast cancer than for those with other cancers. This study examines utilization of two key oncology services across cancer sites: consultation with an oncologist and receipt of treatment. PATIENTS AND METHODS: All residents of Alberta, Canada, who were diagnosed in 2005 with breast, colon, rectal, or lung cancer and had a disease stage that should be treated with chemotherapy, radiation therapy, or hormonal therapy were included. Data were obtained from the Alberta Cancer Registry and electronic cancer medical records. Percentages of patients who had a consultation and who received treatment were compared. Multivariable log-binomial regression models were used to identify patient characteristics associated with not having the outcomes.
RESULTS: A much higher percentage of patients with breast cancer had consultations and received treatment (92% and 83%, respectively) than those with colon (83% and 59%), rectal (86% and 73%), or lung (77% and 66%) cancer. Age, disease stage, region of residence, and surgery status are related to having a consultation and/or receiving treatment but the relationship varies by cancer site.
CONCLUSION: Efforts are needed to eliminate disparities in utilization of key cancer services across cancer sites.

Entities:  

Mesh:

Year:  2011        PMID: 21278218     DOI: 10.1093/annonc/mdq692

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  4 in total

Review 1.  Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours.

Authors:  Christina Sinding; Rachel Warren; Donna Fitzpatrick-Lewis; Jonathan Sussman
Journal:  Support Care Cancer       Date:  2014-08-14       Impact factor: 3.603

2.  Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.

Authors:  Bernardo H L Goulart; Carolina M Reyes; Catherine R Fedorenko; David G Mummy; Sacha Satram-Hoang; Lisel M Koepl; David K Blough; Scott D Ramsey
Journal:  J Oncol Pract       Date:  2013-01       Impact factor: 3.840

3.  Association between the availability of medical oncologists and initiation of chemotherapy for patients with stage III colon cancer.

Authors:  Chun Chieh Lin; Katherine S Virgo
Journal:  J Oncol Pract       Date:  2013-01       Impact factor: 3.840

Review 4.  Barriers to accessing radiation therapy in Canada: a systematic review.

Authors:  Caitlin Gillan; Kaleigh Briggs; Alejandro Goytisolo Pazos; Melanie Maurus; Nicole Harnett; Pamela Catton; David Wiljer
Journal:  Radiat Oncol       Date:  2012-10-12       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.